Clinical trial
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody…
NCT00199875 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00199875 |
|---|---|
| Title | Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 |
| Official title | Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Collaborators | Memorial Sloan Kettering Cancer Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma, Kidney Neoplasm, Renal Cancer, Kidney Cancer |
| Intervention type | Drug |
| Interventions | Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250) |
| Enrollment | 18 |
| Start date | Jul 6, 2005 |
| Primary completion | Mar 14, 2013 |
| Completion | Mar 14, 2013 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 10, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: